O
ELV icon

Ossiam’s Elevance Health ELV Stock Holding History

Ossiam’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
4,662
-524
-10% -$172K 0.02% 195
2025
Q4 		$1.82M Sell
5,186
-4,455
-46% -$1.51M 0.04% 160
2025
Q3 		$3.12M Sell
9,641
-367
-4% -$114K 0.04% 263
2025
Q2 		$3.89M Sell
10,008
-1,812
-15% -$729K 0.04% 192
2025
Q1 		$5.14M Buy
11,820
+6,812
+136% +$2.73M 0.07% 132
2024
Q4 		$1.85M Sell
5,008
-511
-9% -$214K 0.03% 248
2024
Q3 		$2.87M Sell
5,519
-5,631
-51% -$3.01M 0.06% 163
2024
Q2 		$6.04M Buy
11,150
+2,460
+28% +$1.3M 0.11% 100
2024
Q1 		$4.51M Buy
8,690
+1,032
+13% +$513K 0.08% 150
2023
Q4 		$3.61M Buy
7,658
+2,160
+39% +$999K 0.06% 150
2023
Q3 		$2.39M Sell
5,498
-32,410
-85% -$14.7M 0.04% 184
2023
Q2 		$16.8M Buy
37,908
+30,565
+416% +$14.1M 0.3% 78
2023
Q1 		$3.38M Buy
7,343
+4,361
+146% +$2.08M 0.07% 151
2022
Q4 		$1.53M Sell
2,982
-924
-24% -$469K 0.04% 223
2022
Q3 		$1.77M Buy
3,906
+2,442
+167% +$1.17M 0.05% 201
2022
Q2 		$706K Sell
1,464
-11,426
-89% -$5.65M 0.02% 261
2022
Q1 		$6.33M Buy
12,890
+12,734
+8,163% +$5.82M 0.17% 90
2021
Q4 		$72K Buy
156
+73
+88% +$30.7K ﹤0.01% 381
2021
Q3 		$31K Sell
83
-807
-91% -$307K ﹤0.01% 410
2021
Q2 		$342K Sell
890
-2,388
-73% -$913K 0.01% 352
2021
Q1 		$1.18M Buy
3,278
+3,184
+3,387% +$1.02M 0.04% 201
2020
Q4 		$30K Sell
94
-19,906
-100% -$6.11M ﹤0.01% 398
2020
Q3 		$5.37M Buy
+20,000
New +$5.38M 0.22% 77
2020
Q2 		– Sell
-2,074
Closed -$471K – 440
2020
Q1 		$471K Sell
2,074
-53,889
-96% -$14.7M 0.03% 246
2019
Q4 		$16.9M Buy
55,963
+49,512
+768% +$13.6M 1.29% 15
2019
Q3 		$1.55M Buy
6,451
+6,014
+1,376% +$1.65M 0.11% 133
2019
Q2 		$123K Sell
437
-651
-60% -$178K 0.01% 363
2019
Q1 		$312K Sell
1,088
-3,128
-74% -$905K 0.03% 198
2018
Q4 		$1.11M Buy
+4,216
New +$1.16M 0.17% 111

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Ossiam's ELV Position: Q1 2026 in Review

Ossiam reduced its Elevance Health (ELV) stake by 10% in Q1 2026, selling an estimated $172K and leaving 4,662 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #195.

Ossiam first reported a position in ELV in Q4 2018 and has held it in 29 quarters since. The position peaked at $16.9M in Q4 2019. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Ossiam held 4,662 shares of Elevance Health worth $1.36M as of Q1 2026.
  • Ossiam sold 524 Elevance Health shares in Q1 2026, an estimated $172K.
  • Elevance Health made up 0.02% of Ossiam's portfolio in Q1 2026, its #195 holding.
  • Ossiam first reported a position in Elevance Health in Q4 2018 and has held it in 29 quarters since.
  • Ossiam's Elevance Health position peaked at $16.9M in Q4 2019.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.